Recall Register

Food, drugs, devices › Tosoh Bioscience Inc

Device recall: AIA-900 Automated Immunoassay Analyzer performs three methods of immunoassay: an immunoenzymetric (IEMA) or sandwich imm

FDA enforcement event 81172 · Class II · initiated 28 Sep 2017 · status Terminated · terminated 8 Dec 2020

DeviceVoluntary: Firm initiated1 product recordGrove City, OH

Tosoh Bioscience Inc (Grove City, OH) initiated this device recall on 28 Sep 2017; FDA lists 1 product record under event 81172, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 93% of the 1,091 device enforcement events initiated in 2017 carry the same class.

Status: Terminated, terminated 8 Dec 2020. Initiation: voluntary: firm initiated. Tosoh Bioscience Inc has 27 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Tosoh Bioscience Inc, Grove City, OH.

Reason for recall

"The firm has become aware of a potential issue that may affect the mixing motor drive harness and mixing home detection sensor relay harness on your AIA-900 Analyzer. It is possible that the harnesses could rub against the Plarail chain during operation and result in premature wear. If observed, this issue will cause the following system error to be reported D.lane Mix home overrun error [4093]…"

Distribution

"Nationwide distribution. Foreign distribution to Chile, Colombia, Ecuador, Guatemala, Honduras, Panama, Peru, Puerto Rico, Uruguay, and Venezuela."

Product records

Recall numberProductQuantityClassStatusReport date
Z-0602-2019AIA-900 Automated Immunoassay Analyzer performs three methods of immunoassay: an immunoenzymetric (IEMA) or sandwich immunoassay, a competitive binding (EIA) immunoassay, and a two-step immunoenzymetric immunoassay.258Class IITerminated19 Dec 2018

Context

93%of 2017 device events are Class II1,091 events that year
1product record in this eventfirm median: 1
27events on this register for the firm

Other enforcement events for Tosoh Bioscience Inc

InitiatedProduct (first record)TypeClassRecords
12 Jun 2026ST AIA-Pack Testosterone, IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of testosterone in human serum oDeviceClass II1
7 Aug 2020Tosoh Bioscience AIA- PACK HCG Calibrator Set-In Vitro Diagnostic for BHCG Part number 020361 The AIA-Pack BHCG CalibratDeviceClass II2
22 May 2020AIA-900 Analyzer, Part no. 022930, UDI 04560189283992DeviceClass II1
10 Jan 2020AIA-360 Automated Immunoassay Analyzer, Product Code 019945DeviceClass II1
30 Nov 2018AIA-PACK B12 (Vitamin B12) is designed for IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of vitamin B12 DeviceClass II6
5 Oct 2018Hemoglobin A1c Control, Part no. 220232 for use as quality control material to monitor the precision of laboratory testiDeviceClass III1
5 Oct 2018AIA-900 Automated Immunoassay Analyzer, product code 022930 /022930R Product Usage: The AIA-900 is capable of performingDeviceClass II1
5 Oct 2018AIA-900 Analyzer, Product code 022930, 022930RDeviceClass II1
28 Sep 2018AIA-2000 Analyzer, Model Nos. AIA-2000LA, AIA-2000ST - Product Usage: The AIA-2000 is capable of performing three methodDeviceClass II1
28 Sep 2018Tosoh AIA-900 immunoassay AnalyzerDeviceClass II1

All 27 events for Tosoh Bioscience Inc

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "The firm has become aware of a potential issue that may affect the mixing motor drive harness and mixing home detection sensor relay harness on your AIA-900 Analyzer. It is possible that the harnesses could rub against the Plarail chain during operation and result in premature wear. If observed, this issue will cause the following system error to be reported D.lane Mix home overrun error [4093]…"

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Nationwide distribution. Foreign distribution to Chile, Colombia, Ecuador, Guatemala, Honduras, Panama, Peru, Puerto Rico, Uruguay, and Venezuela."

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 8 Dec 2020. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.